Kinfo
Glaukos Corp. logo

Glaukos Corp.

GKOSNYSEHealthcare·US · USD
$165.69
+4.40 (+2.73%)
Prices as of October 9, 2026 · market closed

Price

Key statistics

Valuation
Market cap9.77B USD
Enterprise value9.35B USD
Trailing P/E-50.49
Forward P/E296.48
PEG ratio5.72
Price / sales14.94
Price / book13.39
Profitability
Gross margin81.67%
Operating margin-8.49%
Profit margin-30.69%
Return on assets-5.18%
Return on equity-25.98%
Income (TTM)
Revenue612.84M USD
Gross profit484.88M USD
EBITDA-37.02M USD
Net income-188.05M USD
Diluted EPS-$3.26
Rev. growth (YoY)49.50%
Balance sheet
Total cash286.23M USD
Total debt107.60M USD
Debt / equity15.77
Current ratio5.04
Book value / share$11.60
Cash flow (TTM)
Operating cash flow-950.00K USD
Levered free cash flow15.46M USD
Shares & price
Shares outstanding58.86M
Float56.83M
Held by institutions105.30%
Beta0.70
50-day MA$172.81
200-day MA$135.82
52-week high$191.62
52-week low$73.16
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-07-29-0.21-0.14+33.33%2026-05-190.240.34+41.67%2026-05-110.410.52+26.83%2026-04-29-0.28-0.18+35.71%2026-02-242.522.72+7.94%
About Glaukos Corp.

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for glaucoma, corneal disorders, and retinal diseases. Its product portfolio includes Micro-Invasive Glaucoma Surgery (MIGS) devices, sustained-release drug delivery systems, and bio-activated therapies designed to address chronic eye disease across multiple stages of care. The company serves ophthalmologists, surgeons, and healthcare providers with solutions intended to improve treatment options in both surgical and pharmaceutical settings. Glaukos Corp. is a specialized participant in the eye care market, combining medical devices and medicines to support procedures and therapies used in glaucoma management and corneal health.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Thomas William Burns
Employees
995
Headquarters
Aliso Viejo, CA, United States

Frequently asked questions about Glaukos Corp.